The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Asymmetric Dimethylarginine and Progression of Chronic Kidney Disease: The Mild to Moderate Kidney Disease Study
Abstract
Reduced bioavailability of nitric oxide (NO) is thought to play an important role in progression of renal damage. The hypothesis that the endogenous NO synthase inhibitor asymmetric dimethylarginine (ADMA) is involved in progression of kidney disease was tested. Plasma ADMA concentrations and other putative progression factors were assessed in 227 relatively young patients (45.7 +/- 12.6 yr) with nondiabetic kidney diseases and mild to moderate renal failure. Progression assessed as doubling of serum creatinine and/or renal replacement therapy was evaluated prospectively. Baseline plasma ADMA concentrations in renal patients correlated significantly with serum creatinine (r = 0.595), GFR (r = -0.591), age (r = 0.281), and proteinuria (r = 0.184; all P < 0.01). Patients who reached an end point during follow-up were significantly older (P < 0.05) and had significantly higher creatinine, ADMA, and parathyroid hormone blood concentrations and protein excretion rates at baseline, whereas GFR and hemoglobin were significantly lower (all P < 0.01). Cox regression analysis revealed baseline serum creatinine (odds ratio 2.00; 95% confidence interval [CI] 1.61 to 2.49; P < 0.001) and ADMA (odds ratio 1.47; 95% CI 1.12 to 1.93 for an increment of 0.1 mumol/L; P < 0.006) as independent predictors of disease progression. In patients with ADMA levels above median, progression was significantly faster (P < 0.0001), and their mean follow-up time to a progression end point was 52.8 mo (95% CI 46.9 to 58.8) as compared with 71.6 mo (95% CI 66.2 to 76.9) in patients with ADMA levels below the median. The endogenous NO synthase inhibitor ADMA is significantly associated with progression of nondiabetic kidney diseases. Lowering plasma ADMA concentrations may be a novel therapeutic target to prevent progressive renal impairment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure
Leone, A., Moncada, S., Vallance, P., Calver, A., & Collier, J. (1992) · The Lancet · doi:10.1016/0140-6736(92)90865-z · Cited by 2,107
Maschio, G., Alberti, D., Janin, G., Locatelli, F., Mann, J. F. E., Motolese, M., Ponticelli, C., Ritz, E., & Zucchelli, P. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604113341502 · Cited by 1,766
Self-citationNitric oxide synthase modulates angiogenesis in response to tissue ischemia.
Murohara, T., Asahara, T., Silver, M., Bauters, C., Masuda, H., Kalka, C., Kearney, M., Chen, D., Symes, J. F., Fishman, M. C., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1560 · Cited by 1,200
Zoccali, C., Bode-Böger, S. M., Mallamaci, F., Benedetto, F. A., Tripepi, G., Malatino, L. S., Cataliotti, A., Bellanuova, I., Fermo, I., Frölich, J. C., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)07217-8 · Cited by 1,087
Baylis, C., Mitruka, B., & Deng, A. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115849 · Cited by 729
Achan, V., Broadhead, M., Malaki, M., Whitley, G., Leiper, J., MacAllister, R., & Vallance, P. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000081742.92006.59 · Cited by 593
Kielstein, J. T., Impraim, B., Simmel, S., Bode-Böger, S. M., Tsikas, D., Frölich, J. C., Hoeper, M. M., Haller, H., & Fliser, D. (2004) · Circulation · doi:10.1161/01.cir.0000105764.22626.b1 · Cited by 401
Self-citationAsymmetrical Dimethylarginine: The Über Marker?
Cooke, J. P. (2004) · Circulation · doi:10.1161/01.cir.0000126823.07732.d5 · Cited by 396
Kielstein, J. T., Bo[Combining Diaeresis]ger, R. H., Bode-Bo[Combining Diaeresis]ger, S. M., Fro[Combining Diaeresis]lich, J. D. C., Haller, H., Ritz, E., & Fliser, D. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v131170 · Cited by 369
Self-citationKIELSTEIN, J. T., BÖGER, R. H., BODE-BÖGER, S. M., SCHÄFFER, J., BARBEY, M., KOCH, K. M., & FRÖLICH, J. C. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v103594 · Cited by 361
Self-citationDayoub, H., Achan, V., Adimoolam, S., Jacobi, J., Stuehlinger, M. C., Wang, B.-Y., Tsao, P. S., Kimoto, M., Vallance, P., Patterson, A. J., et al. (2003) · Circulation · doi:10.1161/01.cir.0000101924.04515.2e · Cited by 340
Zoccali, C., Benedetto, F. A., Maas, R., Mallamaci, F., Tripepi, G., Salvatore Malatino, L., & Bo[Combining Diaeresis]ger, R. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v132490 · Cited by 319
KRONENBERG, F., KUEN, E., RITZ, E., JUNKER, R., KO[Combining Diaeresis]NIG, P., KRAATZ, G. D., LHOTTA, K., MANN, J. F. E., MU[Combining Diaeresis]LLER, G. A., NEYER, U., et al. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v111105 · Cited by 248
Self-citationAsymmetric Dimethylarginine, Blood Pressure, and Renal Perfusion in Elderly Subjects
Kielstein, J. T., Bode-Böger, S. M., Frölich, J. C., Ritz, E., Haller, H., & Fliser, D. (2003) · Circulation · doi:10.1161/01.cir.0000060496.23144.a7 · Cited by 211
Self-citationConcentration of dimethyl-L-arginine in the plasma of patients with end-stage renal failure
MacAllister, R. J., Rambausek, M. H., Vallance, P., Williams, D., Hoffmann, K.-H., & Ritz, E. (1996) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/11.12.2449 · Cited by 204
Self-citationTojo, A., Welch, W. J., Bremer, V., Kimoto, M., Kimura, K., Omata, M., Ogawa, T., Vallance, P., & Wilcox, C. S. (1997) · Kidney International · doi:10.1038/ki.1997.490 · Cited by 200
Precision of plasma clearance of iohexol for estimation of GFR in patients with renal disease.
Gaspari, F., Perico, N., Matalone, M., Signorini, O., Azzollini, N., Mister, M., & Remuzzi, G. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v92310 · Cited by 161
Importance of asymmetrical dimethylarginine in cardiovascular risk
Vallance, P. J. (2001) · The Lancet · doi:10.1016/s0140-6736(01)07229-4 · Cited by 123
Nijveldt, R. J., van Leeuwen, P. A., van Guldener, C., Stehouwer, C. D. A., Rauwerda, J. A., & Teerlink, T. (2002) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/17.11.1999 · Cited by 113
Nitric Oxide Modulates Vascular Disease in the Remnant Kidney Model
Kang, D., Nakagawa, T., Feng, L., & Johnson, R. J. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64175-2 · Cited by 112
Fliser, D., Wagner, K.-K., Loos, A., Tsikas, D., & Haller, H. G. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004100852 · Cited by 108
Self-citationMartens‐Lobenhoffer, J., & Bode‐Böger, S. M. (2003) · Journal of Chromatography B · doi:10.1016/j.jchromb.2003.09.050 · Cited by 107
Kronenberg, F., Kuen, E., Ritz, E., Diaeresis]nig, P. K., Kraatz, G. D., Lhotta, K., Mann, J. F. E., Muller, G. A., Neyer, U., Riegel, W., et al. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v132461 · Cited by 88
Self-citationFujihara, C. K., Nucci, G. D., & Zatz, R. (1995) · Journal of the American Society of Nephrology · doi:10.1681/asn.v571498 · Cited by 80
Xiao, S., Wagner, L. J., Schmidt, R. J., & Baylis, C. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.0590041466.x · Cited by 65
Kielstein, J. T., Simmel, S., Bode‐Böger, S. M., Roth, H. J., Schmidt-Gayk, H., Haller, H. G., & Fliser, D. (2004) · Kidney & Blood Pressure Research · doi:10.1159/000078838 · Cited by 63
Self-citationErdely, A., Wagner, L. J., Müller, V., Szabo, A. J., & Baylis, C. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000086476.48686.7d · Cited by 63
Protective Role of Nitric Oxide in a Model of Thrombotic Microangiopathy in Rats
Shao, J., Miyata, T., Yamada, K., Hanafusa, N., WADA, T., GORDON, K. L., Inagi, R., Kurokawa, K., Fujita, T., Johnson, R. J., et al. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v12102088 · Cited by 52
Requirements for initial assay validation and publication in J. Chromatography B.
Lindner, W. F., & Wainer, I. W. (1998) · PubMed · Cited by 43
Compelling drug indications in diabetic and nondiabetic nephropathy
Ritz, E., Dikow, R., & Zeier, M. G. (2004) · Current Hypertension Reports · doi:10.1007/s11906-004-0024-6 · Cited by 2
Self-citation
Cited by
Chronic Kidney Disease: Effects on the Cardiovascular System
Schiffrin, E. L., Lipman, M. L., & Mann, J. F. E. (2007) · Circulation · doi:10.1161/circulationaha.106.678342 · Cited by 1,448
Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Progression of Chronic Kidney Disease
Bolignano, D., Lacquaniti, A., Coppolino, G., Donato, V., Campo, S., Fazio, M. R., Nicocia, G., & Buemi, M. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03530708 · Cited by 561
Biomarkers in chronic kidney disease: a review
Fassett, R. G., Venuthurupalli, S. K., Gobe, G. C., Coombes, J. S., Cooper, M. A., & Hoy, W. E. (2011) · Kidney International · doi:10.1038/ki.2011.198 · Cited by 449
Nitric oxide deficiency in chronic kidney disease
Baylis, C. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00424.2007 · Cited by 413
Biomarkers of renal function, which and when?
Wasung, M. E., Chawla, L. S., & Madero, M. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.08.039 · Cited by 374
Metadata
- Authors
- Fliser, D., Kronenberg, F., Kielstein, J. T., Morath, C., Bode-Bo[Combining Diaeresis]ger, S. M., Haller, H., & Ritz, E.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2005-08
- Volume
- 16
- Issue
- 8
- Pages
- 2456-2461
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2115421882
- Cited by
- 312
- References
- 31
- FWCI
- 14.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.